Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides
Modification of liposome surface with polyethylene glycol was used to improve oligodeoxyribonucleotide (ODN) loading, stability of the resulting complexes, and specificity of cellular delivery of ODN by cationic liposomes. Liposomes composed of a cationic lipid (DOTAP, DOGS, DDAB), a neutral lipid (...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 1998-06, Vol.273 (25), p.15621-15627 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Modification of liposome surface with polyethylene glycol was used to improve oligodeoxyribonucleotide (ODN) loading, stability
of the resulting complexes, and specificity of cellular delivery of ODN by cationic liposomes. Liposomes composed of a cationic
lipid (DOTAP, DOGS, DDAB), a neutral lipid (DOPE), and a phospholipid derivative of polyethylene glycol (PEG-PE) formed a
complex with 18-mer phosphorothioate up to ODN/lipid molar ratio of 0.25. The complexes showed intact vesicular structures
similar to original liposomes and their size (100â130 nm) was unchanged after several weeks of storage, whereas complexes
lacking PEG-PE showed progressive aggregation and/or precipitation. After exposure to human plasma, PEG-modified cationic
liposomes retained over 60% of the originally bound ODN. PEG-coated complexes resulted in 4â13-fold enhancement of the ODN
uptake by human breast cancer cells in serum-supplemented growth medium, relative to free ODN. Complexes containing conjugated
anti-HER2 F(abâ²) fragments at the distal termini of PEG chains efficiently delivered ODN primarily into the cytoplasm and
nuclei of HER2 overexpressing cancer cells and greatly enhanced the biological activity of antisense ODN. The development
of PEG-modified cationic liposomes may lead to improved ODN potency in vivo . |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.273.25.15621 |